...
ilmn-img

Illumina Inc, Common Stock

ILMN

NSQ

$138.68

+$4.88

(3.65%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$22.04B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
935.98K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
1.66M
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.19
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$89 L
$233.42 H
$138.68

About Illumina Inc, Common Stock

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing...more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameILMNSectorS&P500
1-Week Return4.12%1.55%-0.66%
1-Month Return-0.77%1.02%2.29%
3-Month Return-2.7%9.09%8.84%
6-Month Return4.04%15.34%22.28%
1-Year Return-36.33%17.46%32.44%
3-Year Return-64.89%31.65%36.75%
5-Year Return-54.09%78.06%100.86%
10-Year Return-3%199.61%237.34%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue3.54B3.24B4.53B4.58B4.50B[{"date":"2019-12-31","value":77.29,"profit":true},{"date":"2020-12-31","value":70.66,"profit":true},{"date":"2021-12-31","value":98.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.25,"profit":true}]
Cost of Revenue1.08B1.04B1.37B1.61B1.76B[{"date":"2019-12-31","value":61.14,"profit":true},{"date":"2020-12-31","value":58.86,"profit":true},{"date":"2021-12-31","value":77.95,"profit":true},{"date":"2022-12-31","value":91.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit2.47B2.20B3.15B2.97B2.74B[{"date":"2019-12-31","value":78.22,"profit":true},{"date":"2020-12-31","value":69.85,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.23,"profit":true},{"date":"2023-12-31","value":87,"profit":true}]
Gross Margin69.63%68.01%69.69%64.83%60.92%[{"date":"2019-12-31","value":99.92,"profit":true},{"date":"2020-12-31","value":97.6,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.04,"profit":true},{"date":"2023-12-31","value":87.43,"profit":true}]
Operating Expenses1.48B1.62B3.28B7.15B2.97B[{"date":"2019-12-31","value":20.72,"profit":true},{"date":"2020-12-31","value":22.7,"profit":true},{"date":"2021-12-31","value":45.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.48,"profit":true}]
Operating Income985.00M393.00M(123.00M)(4.18B)(1.07B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":39.9,"profit":true},{"date":"2021-12-31","value":-12.49,"profit":false},{"date":"2022-12-31","value":-424.26,"profit":false},{"date":"2023-12-31","value":-108.53,"profit":false}]
Total Non-Operating Income/Expense156.00M455.00M946.00M(8.84B)(67.00M)[{"date":"2019-12-31","value":16.49,"profit":true},{"date":"2020-12-31","value":48.1,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-934.88,"profit":false},{"date":"2023-12-31","value":-7.08,"profit":false}]
Pre-Tax Income1.12B856.00M884.00M(4.34B)(1.12B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":76.57,"profit":true},{"date":"2021-12-31","value":79.07,"profit":true},{"date":"2022-12-31","value":-387.84,"profit":false},{"date":"2023-12-31","value":-99.91,"profit":false}]
Income Taxes128.00M200.00M122.00M68.00M44.00M[{"date":"2019-12-31","value":64,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":61,"profit":true},{"date":"2022-12-31","value":34,"profit":true},{"date":"2023-12-31","value":22,"profit":true}]
Income After Taxes990.00M656.00M762.00M(4.40B)(1.16B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.26,"profit":true},{"date":"2021-12-31","value":76.97,"profit":true},{"date":"2022-12-31","value":-444.85,"profit":false},{"date":"2023-12-31","value":-117.27,"profit":false}]
Income From Continuous Operations990.00M656.00M762.00M(4.40B)(1.16B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.26,"profit":true},{"date":"2021-12-31","value":76.97,"profit":true},{"date":"2022-12-31","value":-444.85,"profit":false},{"date":"2023-12-31","value":-117.27,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income1.00B656.00M762.00M(4.40B)(1.16B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":65.47,"profit":true},{"date":"2021-12-31","value":76.05,"profit":true},{"date":"2022-12-31","value":-439.52,"profit":false},{"date":"2023-12-31","value":-115.87,"profit":false}]
EPS (Diluted)6.584.505.962.120.87[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.39,"profit":true},{"date":"2021-12-31","value":90.58,"profit":true},{"date":"2022-12-31","value":32.22,"profit":true},{"date":"2023-12-31","value":13.22,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ILMN
Cash Ratio 0.67
Current Ratio 1.66
Quick Ratio 1.29

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ILMN
ROA (LTM) -0.53%
ROE (LTM) -18.81%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ILMN
Debt Ratio Lower is generally better. Negative is bad. 0.43
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.57
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 1.76

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ILMN
Trailing PE NM
Forward PE 133.33
P/S (TTM) 4.72
P/B 3.70
Price/FCF 124
EV/R 4.99
EV/Ebitda NM
PEG NM

News

Apple is facing a new antitrust lawsuit that could dethrone the iPhone

Apple CEO Tim Cook takes a selfie with an attendee during an event on September 10, 2019, on Apple’s Cupertino, California campus. | Justin Sullivan/Getty Images Does Apple have a monopoly on smartphones? The Justice Department thinks so. The Biden administration filed a sweeping antitrust lawsuit against Apple Thursday that targets a product that has long been the major revenue driver for the company’s $2.76 trillion business: the iPhone. The Department of Justice, joined by 16 state attorneys general, accused Apple in a New Jersey federal court of maintaining a monopoly on the US market for smartphones, of which the iPhone makes up 65 percent . The complaint alleges that Apple has deliberately thwarted apps, products, and services that would make it easier for users to switch from the iPhone to other smartphones and lower costs for consumers and developers. The company responded in a public statement Thursday that the lawsuit sets a “dangerous precedent, empowering government to take a heavy hand in designing people’s technology.” Apple was one of the last remaining big tech companies that had yet to be hit with an antitrust suit of this magnitude: There are also pending suits against Facebook parent Meta , Amazon , and Google . “Antitrust has changed and is essentially back in an FDR-style,” said Tim Wu , a professor at Columbia Law School and architect of the Biden administration’s antitrust policies . “I think a signature of the FDR-style antitrust was that they didn’t play around the edges.

21 Mar, 2024 a 11:00 pm Vox

Why Illumina Stock Zoomed Higher on Thursday

The company''s chances for winning an important legal battle have improved dramatically.

21 Mar, 2024 a 10:37 pm The Motley Fool

Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors | QSI Stock News

Quantum-Si Incorporated (Nasdaq: QSI) appoints Paula Dowdy, a seasoned executive with 35+ years of experience, to its Board of Directors. Dowdy''s expertise in life sciences and technology industries, including roles at Illumina and Cisco Systems, brings valuable insights to Quantum-Si''s growth strategy and global operations.

21 Mar, 2024 a 8:05 pm Stock Titan

Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a world leading lab automation tools company based in the UK and is an advisor at

21 Mar, 2024 a 8:05 pm Business Wire

EU court should back Illumina’s appeal against EU review of Grail deal, court adviser says

BRUSSELS (Reuters) - Europe''s top court should back U.S. gene sequencing company Illumina''s appeal against the EU antitrust regulators'' review of its …

21 Mar, 2024 a 9:31 am KFGO

Icahn’s All-In: 3 Stocks Billionaire Carl Icahn Is Betting Big On

Billionaire investor Carl Icahn developed a reputation as a corporate raider in the 1980s but is better known today as a shareholder activist. He buys large stakes in undervalued companies to push for changes, often through gaining seats on boards of directors. Most recently Icahn won seats on JetBlue Airways (NASDAQ: JBLU ) board just days after disclosing a 10% stake in the airline. He was also using his access to Illumina ‘s (NASDAQ: ILMN ) board through one of his portfolio managers to sue the biotech’s directors for breach of duty violations. Icahn Enterprises (NYSE: IEP ) is a master limited partnership (MLP) that has $16 billion in assets. It is really a diversified holding company with its assets divided between investments, automotive, food packaging, real estate, home fashion and pharmaceuticals. Virtually all of its assets and liabilities are owned by Icahn Enterprises Holdings , which conducts all of IEP’s operations. Because it doesn’t want to be classified as an investment company, no more than 40% of IEP’s total assets can be invested in investment securities.

18 Mar, 2024 a 8:43 pm InvestorPlace

Illumina: A Biobank for the Americas and a Genomics Lab Power Precision Health for All

NORTHAMPTON, MA / ACCESSWIRE / March 18, 2024 / Illumina:At Galatea Bio, Carlos D. Bustamante enriches the diversity of genomic datasets and brings precision medicine to underserved populationsOrig…

18 Mar, 2024 a 4:50 pm Finanz Nachrichten

FAQs

What is Illumina Inc share price today?

Illumina Inc (ILMN) share price today is $138.68

Can Indians buy Illumina Inc shares?

Yes, Indians can buy shares of Illumina Inc (ILMN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ILMN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Illumina Inc be purchased?

Yes, you can purchase fractional shares of Illumina Inc (ILMN) via the Vested app. You can start investing in Illumina Inc (ILMN) with a minimum investment of $1.

How to invest in Illumina Inc shares from India?

You can invest in shares of Illumina Inc (ILMN) via Vested in three simple steps:

  • Click on Sign Up or Invest in ILMN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Illumina Inc shares
What is Illumina Inc 52-week high and low stock price?

The 52-week high price of Illumina Inc (ILMN) is 233.42. The 52-week low price of Illumina Inc (ILMN) is 89.

What is Illumina Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Illumina Inc (ILMN) is NM

What is Illumina Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Illumina Inc (ILMN) is 3.70

What is Illumina Inc dividend yield?

The dividend yield of Illumina Inc (ILMN) is 0.00%

What is the Market Cap of Illumina Inc?

The market capitalization of Illumina Inc (ILMN) is $22.04B

What is Illumina Inc’s stock symbol?

The stock symbol (or ticker) of Illumina Inc is ILMN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top